Covered recipient · General Payments record
SHABNAM K QASIM
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$11,750.42
- Reported across 675 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,036.48 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $367.82 | 18 |
| Amgen Inc. | $344.79 | 17 |
| GlaxoSmithKline, LLC. | $159.19 | 11 |
| Lilly USA, LLC | $72.59 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.81 | 1 |
| ANI Pharmaceuticals, Inc. | $24.50 | 1 |
| Novo Nordisk AS | $21.90 | 1 |
| Kyowa Kirin, Inc. | $19.88 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.36 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331427 | CMS |
| ABBVIE INC. | $23.39 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331431 | CMS |
| ABBVIE INC. | $14.12 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331435 | CMS |
| ABBVIE INC. | $22.69 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331439 | CMS |
| ABBVIE INC. | $13.60 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331443 | CMS |
| ABBVIE INC. | $25.78 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331447 | CMS |
| ABBVIE INC. | $20.76 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331451 | CMS |
| ABBVIE INC. | $20.94 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331455 | CMS |
| ABBVIE INC. | $13.75 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331459 | CMS |
| ABBVIE INC. | $22.67 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331463 | CMS |
| ABBVIE INC. | $21.78 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331467 | CMS |
| ABBVIE INC. | $23.46 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331470 | CMS |
| ABBVIE INC. | $8.85 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331474 | CMS |
| ABBVIE INC. | $26.20 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331479 | CMS |
| ABBVIE INC. | $17.46 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331483 | CMS |
| ABBVIE INC. | $21.22 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331487 | CMS |
| ABBVIE INC. | $21.14 | 11/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331491 | CMS |
| ABBVIE INC. | $23.65 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105331495 | CMS |
| Amgen Inc. | $16.31 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032860 | CMS |
| Amgen Inc. | $25.01 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032888 | CMS |
| Amgen Inc. | $16.18 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032868 | CMS |
| Amgen Inc. | $28.10 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032894 | CMS |
| Amgen Inc. | $15.57 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117660082 | CMS |
| Amgen Inc. | $22.55 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032900 | CMS |
| Amgen Inc. | $11.05 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117660084 | CMS |
| Amgen Inc. | $24.46 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032907 | CMS |
| Amgen Inc. | $24.90 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032913 | CMS |
| Amgen Inc. | $17.32 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117660086 | CMS |
| Amgen Inc. | $21.37 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032920 | CMS |
| Amgen Inc. | $14.04 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032874 | CMS |
| Amgen Inc. | $12.61 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032926 | CMS |
| Amgen Inc. | $13.10 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032933 | CMS |
| Amgen Inc. | $33.40 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032939 | CMS |
| Amgen Inc. | $24.18 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032880 | CMS |
| Amgen Inc. | $24.64 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116032947 | CMS |
| ANI Pharmaceuticals, Inc. | $24.50 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091152778 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $25.81 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117848169 | CMS |
| GlaxoSmithKline, LLC. | $11.30 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115893141 | CMS |
| GlaxoSmithKline, LLC. | $10.66 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116636468 | CMS |
| GlaxoSmithKline, LLC. | $21.08 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116433029 | CMS |
| GlaxoSmithKline, LLC. | $16.56 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116054459 | CMS |
| GlaxoSmithKline, LLC. | $2.38 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116484487 | CMS |
| GlaxoSmithKline, LLC. | $22.58 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115806501 | CMS |
| GlaxoSmithKline, LLC. | $12.07 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116351484 | CMS |
| GlaxoSmithKline, LLC. | $20.71 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116594122 | CMS |
| GlaxoSmithKline, LLC. | $13.16 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115920227 | CMS |
| GlaxoSmithKline, LLC. | $11.37 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115894796 | CMS |
| GlaxoSmithKline, LLC. | $17.32 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116103984 | CMS |
| Kyowa Kirin, Inc. | $19.88 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127040541 | CMS |
| Lilly USA, LLC | $14.38 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135346346 | CMS |
| Lilly USA, LLC | $20.94 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135413985 | CMS |
| Lilly USA, LLC | $15.63 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135413983 | CMS |
| Lilly USA, LLC | $21.64 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135400223 | CMS |
| Novo Nordisk Inc | $21.90 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097125697 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.